Chengdu Kanghong Pharmaceutical Group
China - ChengduMedical Devices
Focus: Chengdu Kanghong is a China-based pharmaceutical company focused on therapeutics and medical devices with a diverse pipeline spanning CNS, oncology, ophthalmology, and traditional medicine indications. The company appears to be mid-stage with active clinical development programs across multiple therapeutic areas.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Chengdu Kanghong Pharmaceutical Group
AI assessmentNot HiringNo open roles listed right now. Follow Chengdu Kanghong Pharmaceutical Group to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Bosiqing
Stable
Peak
Appears to be a marketed generic or bioequivalent product but limited public data available on revenue or market position.
Pipeline & Clinical Trials
Help build intelligence for Chengdu Kanghong Pharmaceutical Group
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.